DEXCOM, INC. Operating Leases, Rent Expense
DEXCOM, INC. (DXCM) reported Operating Leases, Rent Expense of $12.50 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2021-02-11
- DEXCOM, INC. operating leases, rent expense for the quarter ending 2018-12-31 was $3.90M, a 64.86% decline year-over-year.
- DEXCOM, INC. operating leases, rent expense for the quarter ending 2018-09-30 was $2.90M, a 7.41% increase year-over-year.
- DEXCOM, INC. operating leases, rent expense for the quarter ending 2018-06-30 was $2.90M, a 3.57% increase year-over-year.
- DEXCOM, INC. operating leases, rent expense for the quarter ending 2018-03-31 was $2.80M, a 0.00% change year-over-year.
- DEXCOM, INC. operating leases, rent expense for fiscal 2018 was $12.50M, a 12.61% increase from fiscal 2017.
- DEXCOM, INC. operating leases, rent expense for fiscal 2017 was $11.10M, a 23.33% increase from fiscal 2016.
- DEXCOM, INC. operating leases, rent expense for fiscal 2016 was $9.00M, a 60.71% increase from fiscal 2015.
- DEXCOM, INC. operating leases, rent expense for fiscal 2015 was $5.60M, a 55.56% increase from fiscal 2014.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|
| 2018-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $6.80M derived: sum of 2 quarters · filed 2021-02-11 | $9.70M derived: sum of 3 quarters · filed 2021-02-11 | $12.50M 10-K · filed 2021-02-11 |
| 2018-09-30 | $2.90M 10-Q · filed 2018-11-06 | $5.80M derived: sum of 2 quarters · filed 2018-11-06 | $8.60M 10-Q · filed 2018-11-06 | $19.70M derived: sum of 4 quarters · filed 2019-02-21 |
| 2018-06-30 | $2.90M 10-Q · filed 2018-08-01 | $5.70M 10-Q · filed 2018-08-01 | $16.80M derived: sum of 3 quarters · filed 2019-02-21 | $19.50M derived: sum of 4 quarters · filed 2019-02-21 |
| 2018-03-31 | $2.80M 10-Q · filed 2018-05-02 | $13.90M derived: sum of 2 quarters · filed 2019-02-21 | $16.60M derived: sum of 3 quarters · filed 2019-02-21 | $19.40M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-12-31 | $11.10M 10-K · filed 2019-02-21 | $13.80M derived: sum of 2 quarters · filed 2019-02-21 | $16.60M derived: sum of 3 quarters · filed 2019-02-21 | $11.10M 10-K · filed 2020-02-13 |
| 2017-09-30 | $2.70M 10-Q · filed 2018-11-06 | $5.50M derived: sum of 2 quarters · filed 2018-11-06 | $8.30M 10-Q · filed 2018-11-06 | $10.70M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-06-30 | $2.80M 10-Q · filed 2018-08-01 | $5.60M 10-Q · filed 2018-08-01 | $8.00M derived: sum of 3 quarters · filed 2019-02-21 | $10.40M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-03-31 | $2.80M 10-Q · filed 2018-05-02 | $5.20M derived: sum of 2 quarters · filed 2019-02-21 | $7.60M derived: sum of 3 quarters · filed 2019-02-21 | $9.90M derived: sum of 4 quarters · filed 2019-02-21 |
| 2016-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $4.80M derived: sum of 2 quarters · filed 2019-02-21 | $7.10M derived: sum of 3 quarters · filed 2019-02-21 | $9.00M 10-K · filed 2019-02-21 |
| 2016-09-30 | $2.40M 10-Q · filed 2017-11-01 | $4.70M derived: sum of 2 quarters · filed 2017-11-01 | $6.60M 10-Q · filed 2017-11-01 | |
| 2016-06-30 | $2.30M 10-Q · filed 2017-08-01 | $4.20M 10-Q · filed 2017-08-01 | ||
| 2016-03-31 | $1.90M 10-Q · filed 2017-05-02 | |||
| 2015-12-31 | $5.60M 10-K · filed 2018-02-27 | |||
| 2014-12-31 | $3.60M 10-K · filed 2017-02-28 | |||
| 2013-12-31 | $3.00M 10-K · filed 2016-02-23 | |||
| 2012-12-31 | $2.50M 10-K · filed 2015-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |